KNC Laboratories Co., Ltd.

TSE:6568 Stock Report

Market Cap: JP¥8.4b

KNC Laboratories Management

Management criteria checks 2/4

KNC Laboratories' CEO is Takuya Maoka, appointed in Jan 2023, has a tenure of 2.5 years. directly owns 0.082% of the company’s shares, worth ¥6.93M. The average tenure of the management team and the board of directors is 2.3 years and 6.6 years respectively.

Key information

Takuya Maoka

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.5yrs
CEO ownership0.08%
Management average tenure2.3yrs
Board average tenure6.6yrs

Recent management updates

Recent updates

CEO

Takuya Maoka (57 yo)

2.5yrs
Tenure

Mr. Takuya Maoka is Representative Director & President of KNC Laboratories Co., Ltd. from 2023 and serves as it's Director of Head Office Management Division from 2025. He was Director of Sales & Marketin...

Leadership Team

NamePositionTenureCompensationOwnership
Takuya Maoka
Director of Head Office Management Division2.5yrsno data0.082%
¥ 6.9m
Takamitsu Nagakawa
Corporate Officer and Director of Sales & Marketing Division2.5yrsno datano data
Masahiro Neya
Mana Off of Pharmaceutic. Busi2.1yrsno data0.039%
¥ 3.3m
Kimihiro Kamasaka
Director of Fine Chemicals Division & Directorno datano data0.014%
¥ 1.2m
Koji Matsuo
Corporate Officer & GM of Procurement Dept.less than a yearno datano data
Jun-ichi Miyahara
Corporate Officer & Director of Bio Technology Division3.5yrsno datano data
Ryuichi Inoue
Managing Officer of Bio Technology Business & Directorno datano data0.016%
¥ 1.3m
Satoshi Kobayashi
Corporate Officer & Director of Pharmaceutical Division1yrno datano data
2.3yrs
Average Tenure
63yo
Average Age

Experienced Management: 6568's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Takuya Maoka
Director of Head Office Management Divisionno datano data0.082%
¥ 6.9m
Masahiro Neya
Mana Off of Pharmaceutic. Busi2.1yrsno data0.039%
¥ 3.3m
Kimihiro Kamasaka
Director of Fine Chemicals Division & Director1yrno data0.014%
¥ 1.2m
Ryuichi Inoue
Managing Officer of Bio Technology Business & Director20.3yrsno data0.016%
¥ 1.3m
Yoshihisa Tsukamoto
Outside Audit & Supervisory Board Member8.3yrsno datano data
Hitoshi Miyauchi
Chairman40.5yrsno data10.59%
¥ 894.3m
Yasuhide Kuriyama
Director7.1yrsno data0.052%
¥ 4.4m
Mitsukuni Mouri
Independent Outside Director8.3yrsno datano data
Masami Shigematsu
Outside Audit & Supervisory Board Member6.1yrsno datano data
Yoshihiro Takagi
Full-Time Audit & Supervisory Board Member4.1yrsno data0.23%
¥ 19.8m
Osamu Maruyama
Independent Outside Director3.1yrsno datano data
6.6yrs
Average Tenure
68.5yo
Average Age

Experienced Board: 6568's board of directors are considered experienced (6.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/18 08:03
End of Day Share Price 2025/07/18 00:00
Earnings2016/03/31
Annual Earnings2016/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

KNC Laboratories Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Masao YoshidaIchiyoshi Research Institute Inc.